ATE116301T1 - Chinolinderivate, deren herstellung und verwendung. - Google Patents
Chinolinderivate, deren herstellung und verwendung.Info
- Publication number
- ATE116301T1 ATE116301T1 AT90119128T AT90119128T ATE116301T1 AT E116301 T1 ATE116301 T1 AT E116301T1 AT 90119128 T AT90119128 T AT 90119128T AT 90119128 T AT90119128 T AT 90119128T AT E116301 T1 ATE116301 T1 AT E116301T1
- Authority
- AT
- Austria
- Prior art keywords
- chem
- production
- quinoline derivatives
- alkyl group
- lower alkyl
- Prior art date
Links
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 abstract 1
- 108010054082 Sterol O-acyltransferase Proteins 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Holo Graphy (AREA)
- Detergent Compositions (AREA)
- Measurement Of Radiation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26278289 | 1989-10-06 | ||
| JP32229089 | 1989-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE116301T1 true ATE116301T1 (de) | 1995-01-15 |
Family
ID=26545706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90119128T ATE116301T1 (de) | 1989-10-06 | 1990-10-05 | Chinolinderivate, deren herstellung und verwendung. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5223513A (en:Method) |
| EP (1) | EP0421456B1 (en:Method) |
| KR (1) | KR910007883A (en:Method) |
| CN (1) | CN1050715A (en:Method) |
| AT (1) | ATE116301T1 (en:Method) |
| AU (1) | AU629048B2 (en:Method) |
| CA (1) | CA2026890C (en:Method) |
| DE (1) | DE69015541T2 (en:Method) |
| FI (1) | FI904915A7 (en:Method) |
| HU (1) | HUT55364A (en:Method) |
| IE (1) | IE903454A1 (en:Method) |
| IL (1) | IL95839A (en:Method) |
| NO (1) | NO904300L (en:Method) |
| NZ (1) | NZ235582A (en:Method) |
| PT (1) | PT95515A (en:Method) |
| RU (1) | RU2001910C1 (en:Method) |
| TW (1) | TW205037B (en:Method) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03181465A (ja) * | 1989-12-11 | 1991-08-07 | Takeda Chem Ind Ltd | キノリン誘導体 |
| HUT65748A (en) * | 1991-04-26 | 1994-07-28 | Pfizer | Process for producing 4-aryl-3(heteroarylureido)-quinoline derivatives and pharmaceutical preparations containing them |
| JP2668163B2 (ja) * | 1992-01-23 | 1997-10-27 | ファイザー インク． | コレステロール血症および抗アテローム動脈硬化症薬としての４−アリール−３−（ヘテロアリールウレイド）−１，２−ジヒドロ−２−オキソ−キノリン誘導体 |
| TW241258B (en:Method) * | 1992-04-15 | 1995-02-21 | Takeda Pharm Industry Co Ltd | |
| BR9306421A (pt) * | 1992-05-28 | 1998-09-15 | Pfizer | Novos derivados n-aril e n-heteroariluréia como inbidores da acilcoenzima a:colesterol aciltransferase (acat) |
| US5482967A (en) * | 1992-09-04 | 1996-01-09 | Takeda Chemical Industries, Ltd. | Condensed heterocyclic compounds, their production and use |
| US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
| TW263498B (en:Method) * | 1993-11-10 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
| US6133326A (en) | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
| US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
| WO1999009983A1 (en) * | 1997-08-28 | 1999-03-04 | Bristol-Myers Squibb Company | 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators |
| US6300500B1 (en) | 1998-02-25 | 2001-10-09 | Sumitomo Pharmaceuticals Company, Limited | Preparation of pyridone derivatives using phthalimido containing starting material |
| US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
| CZ20011965A3 (cs) * | 1998-12-04 | 2001-09-12 | Bristol-Myers Squibb Company | Derivát v poloze 3 substituovaného 4-arylchinolin-2-onu jako modulátor draslíkového kanálku |
| PL357041A1 (en) * | 2000-02-02 | 2004-07-12 | Warner-Lambert Company | Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| CA2439663C (en) * | 2001-03-02 | 2012-04-03 | Sumika Fine Chemicals Co., Ltd. | Process for producing quinoline-3-carboxylic acid compound |
| CZ20032898A3 (cs) * | 2001-04-30 | 2004-07-14 | Pfizer Products Inc. | Způsob výroby inhibitorů CETP |
| WO2005030792A2 (en) * | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Quinoline potassium channel inhibitors |
| EA201490846A1 (ru) * | 2011-11-04 | 2014-07-30 | Ф.Хоффманн-Ля Рош Аг | Новые производные арилхинолина |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1216878B (de) * | 1963-04-02 | 1966-05-18 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von coronargefaesserweiternden Derivaten des 7-Hydroxy-2-oxo-1, 2-dihydrochinolins |
| NO133758C (en:Method) * | 1970-04-04 | 1976-06-23 | Takeda Chemical Industries Ltd | |
| JPS555502B1 (en:Method) * | 1971-07-31 | 1980-02-07 | ||
| US4530931A (en) * | 1983-01-03 | 1985-07-23 | Usv Pharmaceutical Corp. | 8-Quinoline carbanilates for the inhibition of lipolysis |
| EP0166354B1 (en) * | 1984-06-26 | 1992-08-05 | Merck & Co. Inc. | Benzofused lactam compounds and pharmaceutical compositions containing them |
| IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
-
1990
- 1990-09-20 TW TW079107912A patent/TW205037B/zh active
- 1990-09-25 IE IE345490A patent/IE903454A1/en unknown
- 1990-09-25 US US07/587,795 patent/US5223513A/en not_active Expired - Fee Related
- 1990-09-28 IL IL9583990A patent/IL95839A/en not_active IP Right Cessation
- 1990-09-28 AU AU63707/90A patent/AU629048B2/en not_active Ceased
- 1990-10-03 NO NO90904300A patent/NO904300L/no unknown
- 1990-10-04 PT PT95515A patent/PT95515A/pt not_active Application Discontinuation
- 1990-10-04 CA CA002026890A patent/CA2026890C/en not_active Expired - Fee Related
- 1990-10-05 HU HU906360A patent/HUT55364A/hu unknown
- 1990-10-05 DE DE69015541T patent/DE69015541T2/de not_active Expired - Fee Related
- 1990-10-05 CN CN90108222A patent/CN1050715A/zh active Pending
- 1990-10-05 FI FI904915A patent/FI904915A7/fi not_active Application Discontinuation
- 1990-10-05 NZ NZ235582A patent/NZ235582A/en unknown
- 1990-10-05 RU SU904831426A patent/RU2001910C1/ru active
- 1990-10-05 AT AT90119128T patent/ATE116301T1/de not_active IP Right Cessation
- 1990-10-05 EP EP90119128A patent/EP0421456B1/en not_active Expired - Lifetime
- 1990-10-06 KR KR1019900015908A patent/KR910007883A/ko not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IE903454A1 (en) | 1991-04-10 |
| PT95515A (pt) | 1991-08-14 |
| AU629048B2 (en) | 1992-09-24 |
| CN1050715A (zh) | 1991-04-17 |
| NO904300L (no) | 1991-04-08 |
| NZ235582A (en) | 1992-03-26 |
| FI904915A7 (fi) | 1991-04-07 |
| JPH03223254A (ja) | 1991-10-02 |
| DE69015541D1 (de) | 1995-02-09 |
| US5223513A (en) | 1993-06-29 |
| CA2026890A1 (en) | 1991-04-07 |
| AU6370790A (en) | 1991-04-11 |
| HUT55364A (en) | 1991-05-28 |
| RU2001910C1 (ru) | 1993-10-30 |
| EP0421456B1 (en) | 1994-12-28 |
| HU906360D0 (en) | 1991-04-29 |
| IL95839A (en) | 1995-03-15 |
| CA2026890C (en) | 2001-09-18 |
| DE69015541T2 (de) | 1995-06-01 |
| KR910007883A (ko) | 1991-05-30 |
| IL95839A0 (en) | 1991-06-30 |
| TW205037B (en:Method) | 1993-05-01 |
| FI904915A0 (fi) | 1990-10-05 |
| EP0421456A3 (en) | 1991-05-29 |
| NO904300D0 (no) | 1990-10-03 |
| EP0421456A2 (en) | 1991-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69015541D1 (de) | Chinolinderivate, deren Herstellung und Verwendung. | |
| DE68920796D1 (de) | Chinolinderivate, ihre Herstellung und Verwendung. | |
| ZA93267B (en) | Novel arylcyloakyl derivatives their production and their use | |
| DE69104593D1 (de) | Herstellung und Verwendung von N-Jodopropargyl-oxycarbonylaminosäure-Estern als antimicrobielle Mittel. | |
| FI952101A0 (fi) | Merkaptanfoerening | |
| NO960239L (no) | Kondenserte indanderivater og farmasöytisk akseptable salter derav | |
| ES543153A0 (es) | Metodo de preparar derivados de b-carbolin-3-oxadiazolilo | |
| ATE158795T1 (de) | Thiazolidindionderivate, ihre herstellung und anwendung | |
| ATE89003T1 (de) | Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen. | |
| DK291488D0 (da) | Alkansulfonanilidderivater | |
| DE3853043D1 (de) | Isochinolinderivate, ihre Herstellung und Verwendung. | |
| DE69116766D1 (de) | Thienopyridin-Derivate, deren Herstellung und Verwendung | |
| ES8604912A1 (es) | Procedimiento de preparacion de nuevos derivados de (arilpi-peraziniletilaminoetoxi)-4 fenol | |
| MY134476A (en) | Aromatic compounds, their production processes and their compositions for the control of insect pests | |
| DE3664467D1 (de) | Pineapple ketone l'alkoxyalkyl derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |